вторник, 21 февраля 2017 г.

Exact Sciences reports 4Q loss

Exact Sciences reports 4Q loss


The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.



from Biotech News